RMTI NASDAQ
Rockwell Medical, Inc.
1W: +3.4%
1M: +7.2%
3M: +54.5%
YTD: +902.0%
1Y: +626.9%
3Y: +367.6%
5Y: +21.0%
$8.65
+0.08 (+0.93%)
Weekly Expected Move ±5.3%
$8
$8
$9
$9
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-04-08
Earliest Filing
2024-07-15
Latest Filing
partner: 2
customer: 2
investor: 2
target: 1
Counterparties (Filed by RMTI)
7 relationshipsCompanies named in RMTI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Evoqua Water Technologies LLC | — | partner | Amendment to Asset Purchase Agreement regarding deferred payments and physical assets | 2024-07-15 | View |
| DaVita Inc. | DVA | customer | Amended and restated products purchase agreement for dialysis concentrates | 2023-09-21 | View |
| Evoqua Water Technologies LLC | — | target | Acquired assets related to hemodialysis concentrates business | 2023-07-11 | View |
| Armistice Capital Master Fund Ltd. | — | investor | Held and exercised warrant to purchase common stock | 2023-07-11 | View |
| Cantor Fitzgerald & Co. | — | partner | Sales agent for the at-the-market offering of common stock | 2022-04-11 | View |
| DaVita Inc. | DVA | customer | Amended supply agreement for dialysis concentrates and securities purchase agreement for preferred stock | 2022-04-08 | View |
| DaVita Inc. | DVA | investor | Investor in Series X Convertible Preferred Stock issuance | 2022-04-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-08-13 | Regulation FD; Exhibits | View | |
| 2026-07-20 | Other Events; Exhibits | View | |
| 2026-06-29 | Bylaws Amendment; Exhibits | View | |
| 2026-06-15 | Shareholder Vote | View | |
| 2026-05-08 | Delisting Notice | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-05-07 | Regulation FD; Exhibits | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2026-03-26 | Regulation FD; Exhibits | View | |
| 2026-01-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-05 | Other Events | View | |
| 2025-11-18 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-09-29 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-20 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR